Keywords: Ranbaxy, Atorvastatin, Generic, Germany, European markets, Pfizer, Daiichi Sankyo, Basics GmbH, Cholesterol lowerer
Ranbaxy debuts generic Lipitor in Germany, ahead of patent expiry
Article | 07 March 2012
The German subsidiary of India’s Ranbaxy Laboratories (AB: BO), Basics GmbH located in Leverkusen, yesterday launched Atorvastatin Basics (10/20/40/80 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
